Trias Joaquim 4
4 · TETRAPHASE PHARMACEUTICALS INC · Filed Mar 27, 2013
Insider Transaction Report
Form 4
Trias Joaquim
10% Owner
Transactions
- Conversion
Series B Convertible Participating Preferred Stock
2013-03-25−234,000→ 0 total→ Common Stock (8,068 underlying) - Conversion
Common Stock
2013-03-25+9,388→ 52,569 total - Conversion
Series A-2 Convertible Participating Preferred Stock
2013-03-25−52,173→ 0 total→ Common Stock (1,800 underlying) - Conversion
Common Stock
2013-03-25+8,068→ 43,181 total - Conversion
Series A-1 Convertible Participating Preferred Stock
2013-03-25−40,000→ 0 total→ Common Stock (1,379 underlying) - Conversion
Series C Convertible Participating Preferred Stock
2013-03-25−272,267→ 0 total→ Common Stock (9,388 underlying) - Conversion
Common Stock
2013-03-25+1,379→ 33,313 total - Conversion
Common Stock
2013-03-25+1,800→ 35,113 total
Footnotes (2)
- [F1]The Series A-1, Series A-2, Series B and Series C Convertible Preferred Stock converted into Common Stock on a 1-for-29 basis upon the closing of the issuer's initial public offering without payment of consideration.
- [F2]Not applicable.